Related Experiment Video
Updated: Feb 5, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate
Erin Sheffels1, Nancy E Sealover1, Chenyue Wang1
1Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Abstract:
About a third of tumors have activating mutations in HRAS, NRAS, or KRAS, genes encoding guanosine triphosphatases (GTPases) of the RAS family. In these tumors, wild-type RAS cooperates with mutant RAS to promote downstream effector activation and cell proliferation and transformation, suggesting that upstream activators of wild-type RAS are important modulators of mutant RAS-driven oncogenesis. The guanine nucleotide exchange factor (GEF) SOS1 mediates KRAS-driven proliferation, but little is understood about the role of SOS2. We found that RAS family members have a hierarchical requirement for the expression and activity of SOS2 to drive cellular transformation. In mouse embryonic fibroblasts (MEFs), SOS2 critically mediated mutant KRAS-driven, but not HRAS-driven, transformation. Sos2 deletion reduced epidermal growth factor (EGF)-dependent activation of wild-type HRAS and phosphorylation of the kinase AKT in cells expressing mutant RAS isoforms. Assays using pharmacological inhibitors revealed a hierarchical requirement for signaling by phosphoinositide 3-kinase (PI3K) in promoting RAS-driven cellular transformation that mirrored the requirement for SOS2. KRAS-driven transformation required the GEF activity of SOS2 and was restored in Sos2-/- MEFs by expression of constitutively activated PI3K. Finally, CRISPR/Cas9-mediated deletion of SOS2 reduced EGF-stimulated AKT phosphorylation and synergized with MEK inhibition to revert the transformed phenotype of human KRAS mutant pancreatic and lung tumor cells. These results indicate that SOS2-dependent PI3K signaling mediates mutant KRAS-driven transformation, revealing therapeutic targets in KRAS-driven cancers. Our data also reveal the importance of three-dimensional culture systems in investigating the mediators of mutant KRAS.
Insights
SOS2 is crucial for mutant KRAS-driven cancer growth by activating PI3K signaling. Targeting SOS2 and PI3K offers new therapeutic strategies for KRAS-mutant cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Activating mutations in RAS family genes (HRAS, NRAS, KRAS) are common in cancers.
- Wild-type RAS cooperates with mutant RAS, driving cell proliferation and transformation.
- The guanine nucleotide exchange factor (GEF) SOS1 is known to mediate KRAS-driven proliferation, but SOS2's role is less understood.
Purpose of the Study:
- To investigate the role of SOS2 in RAS-driven oncogenesis.
- To elucidate the signaling pathways downstream of SOS2 in mediating cellular transformation.
- To identify potential therapeutic targets for KRAS-mutant cancers.
Main Methods:
- Utilized mouse embryonic fibroblasts (MEFs) with and without SOS2.
- Employed CRISPR/Cas9 gene editing to delete SOS2.
- Assessed cellular transformation, epidermal growth factor (EGF)-dependent signaling, and AKT phosphorylation.
- Used pharmacological inhibitors and expression of constitutively activated PI3K.
- Investigated tumor cell lines in 3D culture systems.
Main Results:
- SOS2 is essential for mutant KRAS-driven, but not HRAS-driven, cellular transformation in MEFs.
- SOS2 deletion reduced EGF-dependent activation of HRAS and AKT phosphorylation in cells with mutant RAS.
- A hierarchical requirement for phosphoinositide 3-kinase (PI3K) signaling was observed, mirroring SOS2's role.
- KRAS-driven transformation depended on SOS2's GEF activity and could be restored by activated PI3K in SOS2-deficient cells.
- SOS2 deletion in human KRAS-mutant tumor cells reduced AKT phosphorylation and, with MEK inhibition, reverted the transformed phenotype.
Conclusions:
- SOS2-dependent PI3K signaling is a key mediator of mutant KRAS-driven cellular transformation.
- SOS2 represents a potential therapeutic target in KRAS-driven cancers.
- The study highlights the importance of SOS2 in RAS oncogenesis and suggests targeting the SOS2-PI3K axis.
Related Concept Videos
The Ras Gene
Ras is a...
Nucleotide Excision Repair
Transcription Factors
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Social Exchange Theory
Gas Exchange and Transport

